Americana Partners, LLC Buys 2, Sells 3 in 4th Quarter

Americana Partners, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

811 Louisiana Street Houston, TX 77002

As of the latest 13F report, the guru’s equity portfolio contained 252 stocks valued at a total of $578.00Mil. The top holdings were

According to GuruFocus data, these were Americana Partners, LLC’s top five trades of the quarter.

PIMCO Enhanced Short Maturity Active Exchange-Traded Fund


Americana Partners, LLC reduced their investment in ARCA:MINT by 135,972 shares. The trade had a 2.41% impact on the equity portfolio. During the quarter, the stock traded for an average price of $98.5.

On 01/31/2023, PIMCO Enhanced Short Maturity Active Exchange-Traded Fund traded for a price of $99.47 per share and a market cap of $8.61Bil. The stock has returned -0.27% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

Alphabet Inc


Americana Partners, LLC reduced their investment in NAS:GOOGL by 1,166,122 shares. The trade had a 1.14% impact on the equity portfolio. During the quarter, the stock traded for an average price of $110.89.

On 01/31/2023, Alphabet Inc traded for a price of $96.94 per share and a market cap of $1,262.65Bil. The stock has returned -27.30% over the past year.

GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 9 out of 10.

In terms of valuation, Alphabet Inc has a price-earnings ratio of 19.25, a price-book ratio of 4.96, a price-earnings-to-growth (PEG) ratio of 0.72, a EV-to-Ebitda ratio of 12.82 and a price-sales ratio of 4.60.

The price-to-GF Value ratio is 0.69, earning the stock a GF Value rank of 10.

JPMorgan Ultra-Short Municipal Income ETF


Americana Partners, LLC reduced their investment in BATS:JMST by 101,991 shares. The trade had a 0.93% impact on the equity portfolio. During the quarter, the stock traded for an average price of $50.42.

On 01/31/2023, JPMorgan Ultra-Short Municipal Income ETF traded for a price of $50.7 per share and a market cap of $2.63Bil. The stock has returned 0.84% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

S&P 500 ETF TRUST ETF


During the quarter, Americana Partners, LLC bought 9,492 shares of ARCA:SPY for a total holding of 23,052. The trade had a 0.61% impact on the equity portfolio. During the quarter, the stock traded for an average price of $395.76.

On 01/31/2023, S&P 500 ETF TRUST ETF traded for a price of $400.72 per share and a market cap of $375.89Bil. The stock has returned -7.86% over the past year.

GuruFocus gives the ETF a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, S&P 500 ETF TRUST ETF has a price-earnings ratio of 18.72, a price-book ratio of 3.54, a price-earnings-to-growth (PEG) ratio of 2.20, a EV-to-Ebitda ratio of 14.73 and a price-sales ratio of 2.81.

The price-to-GF Value ratio is 0.00, earning the stock a GF Value rank of 6.

AbbVie Inc


During the quarter, Americana Partners, LLC bought 18,747 shares of NYSE:ABBV for a total holding of 64,663. The trade had a 0.45% impact on the equity portfolio. During the quarter, the stock traded for an average price of $143.5.

On 01/31/2023, AbbVie Inc traded for a price of $145.65 per share and a market cap of $257.58Bil. The stock has returned 9.66% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 10 out of 10.

In terms of valuation, AbbVie Inc has a price-earnings ratio of 19.45, a price-book ratio of 16.11, a price-earnings-to-growth (PEG) ratio of 1.36, a EV-to-Ebitda ratio of 12.51 and a price-sales ratio of 4.46.

The price-to-GF Value ratio is 1.10, earning the stock a GF Value rank of 3.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.